Nutritional Management of CA Patients Flashcards

1
Q

patients with increased risk for malnutrition

A
  • smoking hx
  • low socioeconomic status
  • poor performance status
  • older age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

t/f 20% of ca patients die because of malnutrition

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

top 5 nutrition impact symptoms across all cancers

A
anorexia
dry mouth
nausea
smell intolerance
taste changes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

severity of weight loss depends on ___

A

cancer type, cancer stage, type of surgeries and treatment being done to the patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

release of cytokines lead to __

A

hypermetabolism, anorexia, lean body mass loss, decreased adipose tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

tumor related factors drive up proteolysis and lipid mobilization causing ___

A

losses in lean body mass and losses in adiposity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

a complex metabolic syndrome associated with underlying illness characterized by muscle loss with or without fat loss

A

cachexia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

prominent features of cachexia

A

adults: weight loss
children: growth failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

symptoms of cachexia

A

unintentional weight loss, anorexia, skeletal muscle wasting, lowered quality of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

t/f cancer cachexia always has fat mass loss

A

false, can be with or without this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

t/f cancer cachexia cannot be fully reversed by conventional nutritional support

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

t/f cancer cachexia leads to progressive functional impairment

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pathophysiology of cancer cachexia

A

negative protein energy balance driven by reduced food intake and abnormal metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

central pathophysiological problem in cancer cachexia

A
  • inflammation

- interaction of cytokines and hypothalamic systems interacting with hypothalamus (center for appetite)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

in cancer cachexia, neurotransmitters ad proinflammatory cytokines interact with the brain resulting to ___

A
  • decrease in orexigenic signals (lower appetite stimulation)
  • increase in anorexigenic signals (lack of appetite goes up)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

t/f anorexia is just reduced intake

A

false, the brain is not functioning well to tell the patient that they have to eat!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

treatable causes of weight loss

A

MEALS ON WHEELS

medications
emotional problems
anorexia
late-life paranoid
swallowing disorders

oral factors
no money

wandering (dementia)
hyperthyroidism
hyperparathyroidism
hypoadrenalism
enteric problems
eating problems (inability to feed self)
low salt, low cholesterol
stones, social problems
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

t/f involuntary weight loss combined with low muscle mass was more closely associated with poor quality of life than involuntary weight loss along in community dwelling oler adults

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is sarcopenia

A

muscle wasting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

methods for assessing sarcopenia

A
  • muscle mass: calf circumference
  • muscle strength: handgrip strength, handshake test, handgrip dynamometer
  • performance: sppb, get up and go, 6 min walk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

patient profile in precachexia

A
  • normal
  • weight loss is less/= 5%
  • some anorexia
  • some metabolic changes
22
Q

treatment for precachexia

A
  • monitor and prevention

- be aggressive and manage nutritional status

23
Q

patient profile in cachexia

A
  • weight loss >5% OR
  • bmi < 20 AND weight loss >2% OR
  • presence of sarcopenia and weight loss (>2%)
  • often with reduced food intake/ systemic inflammation
24
Q

treatment for cachexia

A

multimodal approach to reversible factors

25
Q

patient profile in refractory cachexia

A
  • variable degree of cachexia
  • cancer disease both pro-catabolic and no longer responsive to anticancer treatment
  • low performance score
  • <3 mos expected survival
26
Q

treatment for refractory cachexia

A
  • palliation and ethics

- patient is prepared for eventual death

27
Q

adverse effects of radiation therapy depends on

A
  • individual or host response
  • severity/dose of radiation
  • site of radiation administration
28
Q

most vulnerable sites to adverse effects of radiation and chemo therapy

A
  • skin
  • internal mucosa
  • immune system
29
Q

common effects of radiation therapy in h&n cancer

A
  • salivary glands dry up
  • oral mucositis
  • swallowing defects
  • esophagitis
30
Q

adverse effects of chemotherapy depend on ___

A
  • agent used
  • dose and route of administration
  • length of therapy
31
Q

common side effects of chemo

A
  • constipation, diarrhea, vomiting

- fatigue, pain

32
Q

surgical effects on gi function

A
  • tumor site
  • extent of resection
  • adjunctive therapies used
33
Q

espen guidelines on malnutrition in ca pts

A
  • screen them first and assess if there’s malnutrition
  • how aggressive is the malnutrition
  • where is the malnutrition coming from
34
Q

part one of the pg-sga (patient-generated subjective global assessment)

A

patient info

  • weight history
  • food intake
  • symptoms impairing food intake
  • activities and function
35
Q

part 2 of the pg-sga

A

healthcare professional scoring

  • quantifies, qualifies, and scores:
  • weight loss
  • disease and relation to nutritional demang
  • metabolic demand
  • nutrition focused PE
36
Q

t/f you can give the same amount of proteins to a ca patient and a normal pt

A

false, you must give at least more than 1 g/kg. give more than the rda

37
Q

t/f majority of ca patients can eat regular diets

A

true

38
Q

symptoms and factors affecting diminished nutrient intake

A

table 2

39
Q

one way to maximize oral feeding is with ___

A

oral nutritional supplements or foods for special medical purposes

40
Q

content of ons

A
  • carbohydrates (lactose free)
  • fats (essential fa or omega 3 fats)
  • proteins
  • fiber
  • water
41
Q

how to select ons

A

acceptable, available, affordable

42
Q

t/f we must exhaust all tehcniques and methods of oral feeding before considering tube feeding

A

true

43
Q

purpose of neutropenic diets

A

to avoid food more likely to contain infection causing bacteria

44
Q

indications of neutropenic diets

A
  • allogeneic transplants
  • autologous transplant (until 3 mos after)
  • chemo/radio

(chemo pts and bone marrow transplant pts who are extremely immunocompromised)

45
Q

t/f there is sufficient evidence to keep allogeneic transplant patients on the neutropenic diet for 30 days

A

false

46
Q

a more practical guide to the neutropenic diet

A
  • keep food clean
  • proper hand hygiene
  • avoid cross contamination
  • cook the food to proper temp
  • refrigerate properly
47
Q

usual diet vs ketogenic diet

A

usual: 50-55% carbs, 15-20% protein, 25-30% fat
ketogenic: 70-90% fat, 8-10% protein, 2-5% carbs

48
Q

potential risks of ketogenic diet

A
  • inducing weight loss = NO NO!

- acute and chronic effects

49
Q

how to stratify patients in palliative care

A

life expectancy

50
Q

considerations for patients with life expectancy of >3 mos to years

A

improve nutritional status!!

  • treat reversible cause of anorexia
  • note goals of care:
  • weight stabilization or gain
  • improve symptoms that interfere with intake
  • improved energy
  • resolution of metabolic and endo abnormalities
51
Q

considerations for patients with life expectancy of < 3 mos to weeks

A
  • quality of life and wishes of family
  • goals of care: read
  • nutrition support may not change outcomes, but lessen distress